Search

Daniel John Carucci

from Washington, DC
Age ~66
Get Report
Also known as:
Daniel J Carucci, Daniel John Ml Carucci, Daniel John Carruci, Dan L Carucci
Phone and address:
3827 Massachusetts Ave, Washington, DC 20016
(202) 237-5766
Related to:
Evangelos Vazakas
Connected to:
Alexandra I Carucci, 39Briana M Caruccio, 38Felicia J Carucci, 56Giuseppe Carucci, 28Isaia M Carucci, 57Jennifer Carucci, 42Kate Carucci, 44Leonardo D Carucci, 69Vincent P Carucci, 35Andrew J Carufel, 36

Daniel Carucci Phones & Addresses

  • 3827 Massachusetts Ave, Wash, DC 20016 (202) 237-5766
  • 1806 Swann St, Washington, DC 20009 (202) 319-0802
  • Ocean Beach, NY
  • Patchogue, NY
  • New Canaan, CT
  • Pound Ridge, NY
  • 3827 Massachusetts Ave NW, Washington, DC 20016 (202) 744-1626

Work

Position: Production Occupations

Education

School / High School: University of Virginia / Main Campus 1984

Languages

English

Emails

d***[email protected]

Specialities

Family Medicine

Professional Records

Medicine Doctors

Daniel Carucci Photo 1

Dr. Daniel J Carucci, Washington DC - MD (Doctor of Medicine)

View page
Specialties:
Family Medicine
Address:
3827 Massachusetts Ave Nw, Washington, DC 20016
(202) 607-7374 (Phone), (202) 237-5766 (Fax)
Languages:
English
Education:
Medical School
University of Virginia / Main Campus
Graduated: 1984

Resumes

Resumes

Daniel Carucci Photo 2

Director Of Science

View page
Location:
Washington, DC
Industry:
Research
Work:
Us Navy Jun 2001 - Jun 2004
Director, Malaria Program
Foundation For the National Institutes of Health Jun 2001 - Jun 2004
Director of Science
Education:
London School of Hygiene and Tropical Medicine, U. of London 1991 - 1996
Doctorates, Doctor of Philosophy, Molecular Biology London School of Hygiene and Tropical Medicine, U. of London 1990 - 1991
Master of Science, Masters, Medicine University of Virginia School of Medicine 1980 - 1984
Doctor of Medicine, Doctorates, Medicine Washington and Lee University 1976 - 1980
Bachelors, Bachelor of Science, Chemistry
Daniel Carucci Photo 3

President, Global Health Consulting, Inc

View page
Position:
President at Global Health Consulting, Inc
Location:
Washington D.C. Metro Area
Industry:
International Affairs
Work:
Global Health Consulting, Inc since 2010
President
Education:
School name:

Business Records

Name / Title
Company / Classification
Phones & Addresses
Daniel Carucci
Director
The Navy United States Department of
Commercial Physical Research
8901 Wscnsin Ave, Bethesda, MD 20889
8901 Wisconsin Ave, Bethesda, MD 20889
(301) 295-5650, (301) 295-0728
Daniel Carucci
Medical Doctor, President
Global Health Consulting, Inc
Management Consulting Services
3827 Massachusetts Ave NW, Washington, DC 20016
Daniel John Carucci
Daniel Carucci MD,PHD
Family Doctor
3827 Massachusetts Ave NW, Washington, DC 20016
(202) 607-7374

Publications

Us Patents

Malaria Antigen Screening Method

View page
US Patent:
8450055, May 28, 2013
Filed:
Aug 25, 2006
Appl. No.:
11/513439
Inventors:
Joseph T. Bruder - Ijamsville MD, US
Imre Kovesdi - Rockville MD, US
Duncan L. McVey - Derwood MD, US
Douglas E. Brough - Gaithersburg MD, US
C. Richter King - Washington DC, US
Denise Louise Doolan - Camp Hill, AU
Joao Carlos Aguair - Potomac MD, US
Daniel John Carucci - Washington DC, US
Martha Sedegah - Gaithersburg MD, US
Walter R. Weiss - Bethesda MD, US
Keith Limbach - Gaithersburg MD, US
Assignee:
The United States of America as Represented by the Secretary of the Navy - Washington DC
International Classification:
C12Q 1/70
C12N 1/10
A61K 39/00
A61K 39/38
A61K 39/015
C40B 40/02
C40B 50/06
US Classification:
435 5, 4352582, 4241841, 4242681, 4242721, 506 14, 506 26
Abstract:
The invention provides a method of identifying an antigen from a pathogen or a disease antigen comprising the use of an adenoviral vector array comprising two or more different adenoviral vectors, wherein each adenoviral vector comprises a nucleic acid sequence encoding a different antigen of a pathogen. The adenoviral vectors are administered to antigen presenting cells (APCs) in vitro or to an animal in vivo. The immunogenicity of the antigen is measured by screening for an immune response from effector T lymphocytes in vitro and by screening for the absence of pathogen-induced disease onset in vivo.

Antigens And Their Use As Diagnostics And Vaccines Against Species Of Plasmodium

View page
US Patent:
20040202667, Oct 14, 2004
Filed:
Mar 4, 2003
Appl. No.:
10/377636
Inventors:
Daniel Carucci - Washington DC, US
John Yates - La Jolla CA, US
Laurence Florens - La Jolla CA, US
Yimin Wu - Rockville MD, US
International Classification:
C12Q001/68
A61K039/00
A61K039/38
US Classification:
424/184100
Abstract:
Two proteins and their use as substrates for vaccines intended to initiate an immune response in a mammalian subject against infection with species of for use in the diagnosis of infection and for their use in the development of antimalarial drugs. This invention also relates to the diagnostic, isolation and purification assays based on these proteins. This invention further relates to immunological reagents, specifically antibodies directed against these proteins.

Enhancement Of Vaccine-Induced Immune Responses And Protection By Heterologous Boosting With Alphavirus Replicon Vaccines

View page
US Patent:
20050208020, Sep 22, 2005
Filed:
Nov 10, 2004
Appl. No.:
10/988403
Inventors:
Denise Doolan - Rockville MD, US
Gary Brice - , US
Daniel Carucci - Washington DC, US
Kurt Kamrud - Apex NC, US
Jeffrey Chulay - Chapel Hill NC, US
Jonathan Smith - Cary NC, US
International Classification:
A61K048/00
A61K039/12
US Classification:
424093200, 424199100
Abstract:
The inventive subject matter relates to an immunogenic composition and method of enhancing immunogenicity and protective immunity induced by any subunit or whole organism vaccine or combination of vaccines comprising administering to the subject a priming immunization preparation containing an antigen or fragment thereof, said preparation being selected from the group consisting of: a recombinant virus expression system; a recombinant protein antigen or a recombinant polypeptide; a synthetic peptide; a polynucleotide vector; a whole organism or extract and combinations thereof; and a boosting immunization of at least one alphavirus replicon containing an antigen or fragment thereof. The inventive subject matter further relates to an immunogenic composition and method of inducing an immune response that activates both cellular and humoral arms of the immune system.

Plasmodium Falciparum Antigens And Methods Of Use

View page
US Patent:
20060165719, Jul 27, 2006
Filed:
Dec 8, 2003
Appl. No.:
10/537642
Inventors:
Alessandro Sette - La Jolla CA, US
Denise Doolan - Rockville MD, US
Daniel Carucci - Washington DC, US
John Sidney - San Diego CA, US
Scott Southwood - Santee CA, US
Assignee:
Epimmune Inc. - San Diego CA
International Classification:
A61K 39/00
C12Q 1/68
C07H 21/04
C12P 21/06
C12N 1/10
A61K 39/002
C07K 14/445
US Classification:
424191100, 536023700, 435006000, 435069100, 435320100, 435258200, 530350000
Abstract:
the subject invention provides novel antigens and novel polynucleotides encoding these antigens. Also provided by the subject invention are methods of using these antigens and polynucleotides.

Adenoviral Vector-Based Malaria Vaccines

View page
US Patent:
20090148477, Jun 11, 2009
Filed:
Aug 31, 2006
Appl. No.:
12/064554
Inventors:
Joseph T. Bruder - Ijamsville MD, US
Imre Kovesdi - Rockville MD, US
C. Richter King - Washington DC, US
Duncan L. McVey - Derwood MD, US
Damodar R. Ettyreddy - North Potomac MD, US
Denise Louis Doolan - Camp Hill, AU
Daniel John Carucci - Washington DC, US
Keith Limbach - Gaithersburg MD, US
Assignee:
GENVEC, INC. - Gaithersburg MD
International Classification:
A61K 39/015
C12N 15/861
C12N 15/11
A61P 33/06
US Classification:
4242721, 4353201, 536 235
Abstract:
The invention provides adenoviral vectors comprising an adenoviral genome comprising heterologous antigen-encoding nucleic acid sequences, such as nucleic acid sequences, operably linked to promoters. The invention further provides a method of inducing an immune response against malaria in a mammal comprising administering the adenoviral vectors to the mammal.

Plasmodium Falciparum Antigens And Methods Of Use

View page
US Patent:
20120015401, Jan 19, 2012
Filed:
Jul 25, 2011
Appl. No.:
13/189765
Inventors:
Alessandro Sette - La Jolla CA, US
Denise L. Doolan - Rockville MD, US
Daniel J. Carucci - Washington DC, US
John Sidney - San Diego CA, US
Scott Southwood - Santee CA, US
Assignee:
U.S.A as Represented by the Secretary of the Navy, Office of Naval Research (Code 00CC) - Arlington VA
Epimmune Inc. - San Diego CA
International Classification:
C12P 21/02
C12N 1/19
C12N 1/21
C12N 5/10
C07H 21/00
C12N 15/63
US Classification:
435 693, 536 237, 4353201, 4352523, 435362, 435348, 435419, 43525421, 43525423
Abstract:
The subject invention provides novel antigens and novel polynucleotides encoding these antigens. Also provided by the subject invention are methods of using these antigens and polynucleotides.

Malaria Antigen Screening Method

View page
US Patent:
20170219560, Aug 3, 2017
Filed:
Apr 10, 2017
Appl. No.:
15/483427
Inventors:
- Silver Spring MD, US
Imre Kovesdi - Rockville, HU
Duncan L. McVey - Derwood MD, US
Douglas E. Brough - Gaithersburg MD, US
Richter C. King - Washington DC, US
Denise L. Doolan - Camp Hill, AU
Joao C. Aguair - Potomac MD, US
Daniel J. Carucci - Washington DC, US
Martha Sedegah - Gaithersburg MD, US
Walter R. Weiss - Bethesda MD, US
Keith Limbach - Gaithersburg MD, US
Assignee:
United States of America as Represented by the Secretary of the Navy - Silver Spring MD
International Classification:
G01N 33/50
A61K 49/00
C12N 7/00
G01N 33/574
G01N 33/564
C12N 15/10
G01N 33/569
A61K 39/015
Abstract:
The invention provides a method of identifying an antigen from a pathogen or a disease antigen comprising the use of an adenoviral vector array comprising two or more different adenoviral vectors, wherein each adenoviral vector comprises a nucleic acid sequence encoding a different antigen of a pathogen. The adenoviral vectors are administered to antigen presenting cells (APCs) in vitro or to an animal in vivo. The immunogenicity of the antigen is measured by screening for an immune response from effector T lymphocytes in vitro and by screening for the absence of pathogen-induced disease onset in vivo.

Malaria Antigen Screening Method

View page
US Patent:
20170082607, Mar 23, 2017
Filed:
Apr 19, 2013
Appl. No.:
13/866116
Inventors:
Joseph T. Bruder - Ijamsville MD, US
Imre Kovesdi - Rockville MD, US
Duncan L. McVey - Derwood MD, US
Douglas E. Brough - Gaithersburg MD, US
C. Richter King - Washington DC, US
Denise Louise Doolan - Camp Hill, AU
Joao Carlos Aguair - Potomac MD, US
Daniel John Carucci - Washington DC, US
Martha Sedegah - Gaithersburg MD, US
Walter R. Weiss - Bethesda MD, US
Keith Limbach - Gaithersburg MD, US
International Classification:
G01N 33/50
Abstract:
The invention provides a method of identifying an antigen from a pathogen or a disease antigen comprising the use of an adenoviral vector array comprising two or more different adenoviral vectors, wherein each adenoviral vector comprises a nucleic acid sequence encoding a different antigen of a pathogen. The adenoviral vectors are administered to antigen presenting cells (APCs) in vitro or to an animal in vivo. The immunogenicity of the antigen is measured by screening for an immune response from effector T lymphocytes in vitro and by screening for the absence of pathogen-induced disease onset in vivo.
Control profile
Daniel John Carucci from Washington, DC, age ~66 Get Report